Publications
171
Citations
5,858
Est. group size
—
Recurring co-author estimate
Active years
55
Publishing since 1971
This publication record appears to mix together work from multiple different people who share the same name, spanning lung cancer screening and treatment, medical physics, oilfield chemistry, and medieval literary studies. Based on the medicine-related entries, this name is associated with research on lung cancer screening programs, cost-effectiveness of screening, quality of life in screening cohorts, and laboratory studies of lung cancer and mesothelioma biology. Because the topic relevance scores are all listed as zero and the publication list is highly inconsistent across unrelated fields, it is likely that this record conflates several distinct researchers rather than representing a single coherent research program.
Publication counts over the last decade are irregular, with several zero-output years followed by a sharp, isolated spike in 2023, making it difficult to characterize a steady or growing trend.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- John Darnielle and the Two Medieval Geoffreys
Modern Philology · 2025
- Synergistic Scale Inhibitor Blends for Severe Carbonate Scaling Systems
All Days · 2024
- The Elaborate Book
2023
- Supplementary Materials from Patient-Derived Xenograft Establishment from Human Malignant Pleural Mesothelioma
2023
- Data from Patient-Derived Xenograft Establishment from Human Malignant Pleural Mesothelioma
2023
- Data from Patient-Derived Xenograft Establishment from Human Malignant Pleural Mesothelioma
2023
- Supplementary Materials from Patient-Derived Xenograft Establishment from Human Malignant Pleural Mesothelioma
2023
- Supplementary Tables 1-4 from Expression of Chicken Ovalbumin Upstream Promoter-Transcription Factor II Enhances Invasiveness of Human Lung Carcinoma Cells
2023
- Data from Expression of Chicken Ovalbumin Upstream Promoter-Transcription Factor II Enhances Invasiveness of Human Lung Carcinoma Cells
2023
- Data from Expression of Chicken Ovalbumin Upstream Promoter-Transcription Factor II Enhances Invasiveness of Human Lung Carcinoma Cells
2023
- Supplementary Tables 1-4 from Expression of Chicken Ovalbumin Upstream Promoter-Transcription Factor II Enhances Invasiveness of Human Lung Carcinoma Cells
2023
- Synergistic Scale Inhibitor Blends Provide Enhanced Carbonate Scale Management- Laboratory to Field
SPE International Conference on Oilfield Chemistry · 2023
- Further Remarks on the Audience and Public of <i>Piers Plowman</i>
The Yearbook of Langland Studies · 2023
- Enhanced Carbonate Scale Inhibition in the North Sea via Synergistic Inhibitor Molecule Blends
Journal of Petroleum Technology · 2023
- OP26 Effect of COVID-19 on presentations of decompensated liver disease in Scotland
Abstracts · 2022
- Journal of Thoracic Oncology×2
- The Yearbook of Langland Studies×2
- The Lancet Oncology×1
- Clinical Cancer Research×1
- BMJ Open×1
- Alberto Revelo
Medicine · The Ohio State University
- Manny Coker‐Schwimmer
Medicine · The Ohio State University
- A. Foster
Medicine · Indiana University
- Daniel Jones
Medicine · The Ohio State University
- Robert E. Merritt
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 20, 2026.
Claim or correct this profile